Birgitta Benda

Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial

Tamas Koncz, David Gruben, Ricardo Blanco, 2013, The Lancet.